Eric H Raabe

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. pmc High-risk medulloblastoma: does c-myc amplification overrule histopathology?
    Eric H Raabe
    Pediatr Blood Cancer 54:344-5. 2010
  2. pmc Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma
    Sama Ahsan
    Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, 1800 Orleans St, 21287 Baltimore, MD, USA
    Acta Neuropathol Commun 2:59. 2014
  3. pmc Methylome alterations "mark" new therapeutic opportunities in glioblastoma
    Eric H Raabe
    Division of Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Cancer Cell 22:417-8. 2012
  4. pmc Subtotal splenic embolization is a safe and effective treatment for isolated splenic vascular tumors associated with consumptive coagulopathy
    Eric H Raabe
    Division of Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Pediatr Hematol Oncol 33:383-6. 2011
  5. pmc BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model
    Eric H Raabe
    Division of Pediatric Oncology and Departments of Pathology and Pediatrics and Adolescent Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Clin Cancer Res 17:3590-9. 2011
  6. pmc The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma
    Harpreet Kaur
    Division of Neuropathology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA Division of Pediatric Oncology, Johns Hopkins University, Bloomberg Children s Hospital, Room 11379, 1800 Orleans St, Baltimore, MD 21287, USA
    Cancer Lett 377:55-64. 2016
  7. pmc Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target
    Melanie F Weingart
    Division of Neuropathology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
    Oncotarget 6:3165-77. 2015
  8. pmc Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target
    Marianne Hütt-Cabezas
    Corresponding Authors Fausto J Rodriguez, MD, Division of Neuropathology, Johns Hopkins Hospital, 1800 Orleans Street, Baltimore, MD 21231 Eric H Raabe, MD, PhD, Division of Neuropathology, Johns Hopkins Hospital, 1800 Orleans Street, Baltimore, MD 21231
    Neuro Oncol 15:1604-14. 2013
  9. pmc LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program
    Xing gang Mao
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Oncotarget 4:1050-64. 2013
  10. pmc The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity
    Harpreet Kaur
    From the Division of Neuropathology and Sidney Kimmel Comprehensive Cancer Center HK, MH C, MFW, CGE, EHR, Division of Pediatric Oncology EHR, Johns Hopkins University School of Medicine, Bloomberg Children s Hospital, Baltimore, Maryland Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina YK, BEW and Division of Hematology, Oncology, and Blood and Bone Marrow Transplant, Children s Hospital Los Angeles JX, AE E and the University of Southern California AE E, Los Angeles, California
    J Neuropathol Exp Neurol 74:177-85. 2015

Collaborators

  • Fausto J Rodriguez
  • Brent A Orr
  • Deepali Jain
  • Yazmin Odia
  • Elisabeth J Rushing
  • Kenneth J Cohen
  • Charles G Eberhart
  • Marianne Hütt-Cabezas
  • Harpreet Kaur
  • Xing gang Mao
  • Melanie F Weingart
  • Isabella Taylor
  • Anat Erdreich-Epstein
  • Yasumichi Kuwahara
  • Bernard E Weissman
  • Jingying Xu
  • Melanie Weingart
  • Sama Ahsan
  • Lauren Huey
  • Sabeen Zulfiqar Ali
  • Qian Chu
  • Jacquelyn J Roth
  • Tracy M Busse
  • Jaclyn A Biegel
  • Antoinette Price
  • Jeffrey Rubens
  • Rachael Maynard
  • Sariah J Allen
  • Javad Nazarian
  • Michael C Haffner
  • Katherine E Warren
  • Leomar Y Ballester
  • Ajay Vaghasia
  • Martha Quezado
  • Ulf Kahlert
  • David Zagzag
  • Anand K D Rajan
  • Guido Nikkhah
  • Iren Horkayne-Szakaly
  • J Douglas Cameron
  • Smit Shah
  • Jarek Maciaczyk
  • Matthias A Karajannis

Detail Information

Publications10

  1. pmc High-risk medulloblastoma: does c-myc amplification overrule histopathology?
    Eric H Raabe
    Pediatr Blood Cancer 54:344-5. 2010
  2. pmc Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma
    Sama Ahsan
    Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, 1800 Orleans St, 21287 Baltimore, MD, USA
    Acta Neuropathol Commun 2:59. 2014
    ..An H-score was derived by multiplying intensity (0-2) by percentage of positive tumor nuclei (0-100%)...
  3. pmc Methylome alterations "mark" new therapeutic opportunities in glioblastoma
    Eric H Raabe
    Division of Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Cancer Cell 22:417-8. 2012
    ..These findings suggest novel opportunities for therapeutics for this dreaded disease...
  4. pmc Subtotal splenic embolization is a safe and effective treatment for isolated splenic vascular tumors associated with consumptive coagulopathy
    Eric H Raabe
    Division of Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Pediatr Hematol Oncol 33:383-6. 2011
    ..One child was successfully treated by subtotal embolization of the spleen, whereas the second child required splenectomy after an initial embolization improved--but did not fully control--his consumptive coagulopathy...
  5. pmc BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model
    Eric H Raabe
    Division of Pediatric Oncology and Departments of Pathology and Pediatrics and Adolescent Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Clin Cancer Res 17:3590-9. 2011
    ..We investigated the functional effect of constitutive BRAF activation in normal human neural stem and progenitor cells to determine its role in tumor induction in the brain...
  6. pmc The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma
    Harpreet Kaur
    Division of Neuropathology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA Division of Pediatric Oncology, Johns Hopkins University, Bloomberg Children s Hospital, Room 11379, 1800 Orleans St, Baltimore, MD 21287, USA
    Cancer Lett 377:55-64. 2016
    ..Ectopic expression of HMGA2 in GBM cell lines promoted stemness, invasion, and tumorigenicity. Our data suggests that targeting HMGA2 in GBM may be therapeutically beneficial. ..
  7. pmc Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target
    Melanie F Weingart
    Division of Neuropathology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
    Oncotarget 6:3165-77. 2015
    ..These data implicate LIN28/RAS/MAP kinase as key drivers of AT/RT tumorigenesis and indicate that targeting this pathway may be a therapeutic option in this aggressive pediatric malignancy. ..
  8. pmc Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target
    Marianne Hütt-Cabezas
    Corresponding Authors Fausto J Rodriguez, MD, Division of Neuropathology, Johns Hopkins Hospital, 1800 Orleans Street, Baltimore, MD 21231 Eric H Raabe, MD, PhD, Division of Neuropathology, Johns Hopkins Hospital, 1800 Orleans Street, Baltimore, MD 21231
    Neuro Oncol 15:1604-14. 2013
    ..Here we further evaluate the role of the mTORC1/mTORC2 pathway in order to better direct pharmacologic blockade in these common childhood tumors...
  9. pmc LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program
    Xing gang Mao
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Oncotarget 4:1050-64. 2013
    ..Taken together, these data suggest a role for LIN28A in high grade gliomas and illustrate an HMGA2-associated, pro-invasive program that can be activated in GBM by LIN28A-mediated suppression of let-7 microRNAs. ..
  10. pmc The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity
    Harpreet Kaur
    From the Division of Neuropathology and Sidney Kimmel Comprehensive Cancer Center HK, MH C, MFW, CGE, EHR, Division of Pediatric Oncology EHR, Johns Hopkins University School of Medicine, Bloomberg Children s Hospital, Baltimore, Maryland Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina YK, BEW and Division of Hematology, Oncology, and Blood and Bone Marrow Transplant, Children s Hospital Los Angeles JX, AE E and the University of Southern California AE E, Los Angeles, California
    J Neuropathol Exp Neurol 74:177-85. 2015
    ..Our results indicate a role for HMGA2 in AT/RT in vitro and in vivo and demonstrate that HMGA2 is a potential therapeutic target in these lethal pediatric tumors. ..